Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients
- PMID: 24587002
- PMCID: PMC3935943
- DOI: 10.1371/journal.pone.0089741
Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients
Abstract
Objective: To estimate the risk for developing a defined neurodegenerative syndrome in a large cohort of idiopathic REM sleep behavior disorder (IRBD) patients with long follow-up.
Methods: Using the Kaplan-Meier method, we estimated the disease-free survival rate from defined neurodegenerative syndromes in all the consecutive IRBD patients diagnosed and followed-up in our tertiary referal sleep center between November 1991 and July 2013.
Results: The cohort comprises 174 patients with a median age at diagnosis of IRBD of 69 years and a median follow-up of four years. The risk of a defined neurodegenerative syndrome from the time of IRBD diagnosis was 33.1% at five years, 75.7% at ten years, and 90.9% at 14 years. The median conversion time was 7.5 years. Emerging diagnoses (37.4%) were dementia with Lewy bodies (DLB) in 29 subjects, Parkinson disease (PD) in 22, multiple system atrophy (MSA) in two, and mild cognitive impairment (MCI) in 12. In six cases, in whom postmortem was performed, neuropathological examination disclosed neuronal loss and widespread Lewy-type pathology in the brain in each case.
Conclusions: In a large IRBD cohort diagnosed in a tertiary referal sleep center, prolonged follow-up indicated that the majority of patients are eventually diagnosed with the synucleinopathies PD, DLB and less frequently MSA. IRBD represented the prodromal period of these conditions. Our findings in IRBD have important implications in clinical practice, in the investigation of the early pathological events occurring in the synucleinopathies, and for the design of interventions with potential disease-modifying agents.
Conflict of interest statement
Figures


Similar articles
-
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.Lancet Neurol. 2013 May;12(5):443-53. doi: 10.1016/S1474-4422(13)70056-5. Epub 2013 Apr 3. Lancet Neurol. 2013. PMID: 23562390
-
Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.Lancet Neurol. 2021 Mar;20(3):203-212. doi: 10.1016/S1474-4422(20)30449-X. Lancet Neurol. 2021. PMID: 33609478
-
Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series.Sleep Med. 2013 Aug;14(8):744-8. doi: 10.1016/j.sleep.2012.10.009. Epub 2013 Jan 22. Sleep Med. 2013. PMID: 23347909
-
Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22. Sleep Med. 2013. PMID: 23886593 Free PMC article.
-
Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions.Lancet Neurol. 2016 Apr;15(4):405-19. doi: 10.1016/S1474-4422(16)00057-0. Lancet Neurol. 2016. PMID: 26971662 Review.
Cited by
-
Phenoconversion from Idiopathic Rapid Eye Movement Sleep Behavior Disorder to Lewy Body Disease.Mov Disord Clin Pract. 2018 Oct 3;5(5):506-511. doi: 10.1002/mdc3.12647. eCollection 2018 Sep-Oct. Mov Disord Clin Pract. 2018. PMID: 30515439 Free PMC article.
-
Recent Advances in Biomarkers for Parkinson's Disease.Front Aging Neurosci. 2018 Oct 11;10:305. doi: 10.3389/fnagi.2018.00305. eCollection 2018. Front Aging Neurosci. 2018. PMID: 30364199 Free PMC article.
-
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.J Neurol. 2023 Sep;270(9):4393-4402. doi: 10.1007/s00415-023-11785-0. Epub 2023 May 26. J Neurol. 2023. PMID: 37233802
-
Cognitive Function Characteristics of Parkinson's Disease with Sleep Disorders.Parkinsons Dis. 2017;2017:4267353. doi: 10.1155/2017/4267353. Epub 2017 Apr 18. Parkinsons Dis. 2017. PMID: 28484661 Free PMC article.
-
Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.Neurotherapeutics. 2021 Jan;18(1):107-123. doi: 10.1007/s13311-020-00983-7. Epub 2021 Jan 6. Neurotherapeutics. 2021. PMID: 33410105 Free PMC article. Review.
References
-
- Iranzo A, Santamaria J, Tolosa E (2009) The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 13: 385–401. - PubMed
-
- Arnulf I (2012) REM sleep behavior disorder: motor manifestations and pathophysiology. Mov Disord 27: 677–689. - PubMed
-
- Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 46: 388–393. - PubMed
-
- Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older males initially diagnosed with idiopathic REM sleep behavior disorder (IBD): 16 year update on a previously reported series. Sleep Med 14: 744–748. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical